European Commission Approves Uplizna for Generalised Myasthenia Gravisnuaxia30 de jul.0 min de leituraAvaliado com NaN de 5 estrelas.
FDA approves Hovilpri as novel oral treatment for refractory herpes simplex infections in immunocompromised adults
FDA approves Teva's Weltruza as first once-monthly subcutaneous olanzapine injection for schizophrenia
Biohaven licenses IgG degrader portfolio to Ono Pharma in Asian agreement worth up to $100m in near-term payments
Comentários